Company overview

ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.

2Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells. immunomodulatory targets and armed target-specific NK cells
Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells.